Virtu Financial LLC Enanta Pharmaceuticals Inc Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$10.08 - $17.46 $110,144 - $190,785	10,927 New	10,927 $191,000
Q2 2019 Aug 13, 2019	SELL	$81.3 - $97.35 $219,672 - $263,039	-2,702 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$69.08 - $105.66 $203,233 - $310,851	-2,942 Reduced 52.13%	2,702 $258,000
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $482,336 - $713,232	5,644 New	5,644 $482,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.